16 September 2026 editorial review · Item
E-islet 01 allogeneic human regenerative islets: review notes
These notes document the scope actually reviewed, including source-access limits. They are not independent clinical certification or a guarantee that every claim was verified.
Read the item evidence page →Preventing and curing evidence review — 16 September 2026
- Disposition: reviewed; no confirmed content change. Current item
lastReviewed: 2026-08-27. - Claim check: The current E-islet 01 trial is distinct from the 2026 three-recipient T1D publication and 2024 T2D kidney-recipient case. DOI/title metadata were verified, but the full 2026 case letter was inaccessible in this pass. No drug-free benefit or posted trial results were inferred.
- Registry NCT07126873: RECRUITING; updated 2025-08-22; enrollment 21 (ESTIMATED); primary completion 2027-12-31 (ESTIMATED); results not posted in retrieved record.
- Primary publication/regulatory sources checked or consulted: S2213-8587%2825%2900423-1; s41421-024-00662-3.